Literature DB >> 16112849

Transfer of lipophilic drugs between liposomal membranes and biological interfaces: consequences for drug delivery.

Alfred Fahr1, Peter van Hoogevest, Sylvio May, Nill Bergstrand, Mathew L S Leigh.   

Abstract

This review paper describes the present knowledge on the interaction of lipophilic, poorly water soluble, drugs with liposomal membranes and the reversibility of this interaction. This interaction is discussed in the context of equilibrium and spontaneous transfer kinetics of the drug, when the liposomes are brought in co-dispersion with other artificial or natural phospholipid membranes in an aqueous medium. The focus is on drugs, which have the potential to partition (dissolve) in a lipid membrane but do not perturb membranes. The degree of interaction is described as solubility of a drug in phospholipid membranes and the kinetics of transfer of a lipophilic drug between membranes. Finally, the consequences of these two factors on the design of lipid based carriers for oral, as well as parenteral use, for lipophilic drugs and lead selection of oral lipophilic drugs is described. Since liposomes serve as model-membranes for natural membranes, the assessment of lipid solubility and transfer kinetics of lipophilic drug using liposome formulations may additionally have predictive value for bioavailability and biodistribution and the pharmacokinetics of lipophilic drugs after parenteral as well as oral administration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16112849     DOI: 10.1016/j.ejps.2005.05.012

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  39 in total

1.  Sterically stabilized liposomes incorporating the novel anticancer agent phospho-ibuprofen (MDC-917): preparation, characterization, and in vitro/in vivo evaluation.

Authors:  George Mattheolabakis; Ting Nie; Panayiotis P Constantinides; Basil Rigas
Journal:  Pharm Res       Date:  2011-11-10       Impact factor: 4.200

2.  Characterization of the colloidal properties, in vitro antifungal activity, antileishmanial activity and toxicity in mice of a di-stigma-steryl-hemi-succinoyl-glycero-phosphocholine liposome-intercalated amphotericin B.

Authors:  Maryam Iman; Zhaohua Huang; Francis C Szoka; Mahmoud R Jaafari
Journal:  Int J Pharm       Date:  2011-01-26       Impact factor: 5.875

3.  Biodistribution and In Vivo Antileishmanial Activity of 1,2-Distigmasterylhemisuccinoyl-sn-Glycero-3-Phosphocholine Liposome-Intercalated Amphotericin B.

Authors:  Maryam Iman; Zhaohua Huang; Seyedeh Hoda Alavizadeh; Francis C Szoka; Mahmoud R Jaafari
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

4.  Membrane Loaded Copper Oleate PEGylated Liposome Combined with Disulfiram for Improving Synergistic Antitumor Effect In Vivo.

Authors:  Lingli Zhou; Liu Yang; Chulei Yang; Yi Liu; Qiuyue Chen; Wenli Pan; Qing Cai; Lifeng Luo; Lu Liu; Shan Jiang; Haibing He; Yu Zhang; Tian Yin; Xing Tang
Journal:  Pharm Res       Date:  2018-05-23       Impact factor: 4.200

5.  Multicompartimental nanoparticles for co-encapsulation and multimodal drug delivery to tumor cells and neovasculature.

Authors:  Lívia Palmerston Mendes; Marilisa Pedroso Nogueira Gaeti; Paulo Henrique Marcelino de Ávila; Marcelo de Sousa Vieira; Bruna Dos Santos Rodrigues; Renato Ivan de Ávila Marcelino; Lílian Cristina Rosa Dos Santos; Marize Campos Valadares; Eliana Martins Lima
Journal:  Pharm Res       Date:  2013-10-30       Impact factor: 4.200

6.  Non-Covalent Assembly Method that Simultaneously Endows a Liposome Surface with Targeting Ligands, Protective PEG Chains, and Deep-Red Fluorescence Reporter Groups.

Authors:  Scott K Shaw; Wenqi Liu; Seamus P Brennan; María de Lourdes Betancourt-Mendiola; Bradley D Smith
Journal:  Chemistry       Date:  2017-08-09       Impact factor: 5.236

7.  Fluorescence-quenching of a liposomal-encapsulated near-infrared fluorophore as a tool for in vivo optical imaging.

Authors:  Felista L Tansi; Ronny Rüger; Markus Rabenhold; Frank Steiniger; Alfred Fahr; Ingrid Hilger
Journal:  J Vis Exp       Date:  2015-01-05       Impact factor: 1.355

8.  Liposomal formulation of HIF-1α inhibitor echinomycin eliminates established metastases of triple-negative breast cancer.

Authors:  Christopher M Bailey; Yan Liu; Gong Peng; Huixia Zhang; Miao He; Duxin Sun; Pan Zheng; Yang Liu; Yin Wang
Journal:  Nanomedicine       Date:  2020-07-30       Impact factor: 5.307

9.  Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug.

Authors:  Olga B Garbuzenko; Maha Saad; Seema Betigeri; Min Zhang; Alexandre A Vetcher; Viatcheslav A Soldatenkov; David C Reimer; Vitaly P Pozharov; Tamara Minko
Journal:  Pharm Res       Date:  2008-10-29       Impact factor: 4.200

10.  Targeted intestinal delivery of supersaturated itraconazole for improved oral absorption.

Authors:  Dave A Miller; James C DiNunzio; Wei Yang; James W McGinity; Robert O Williams
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.